earnings
confidence high
sentiment neutral
materiality 0.70
Revvity issues preliminary Q4 2023 revenue at least $690M with organic decline of 4-7%, EPS guidance reaffirmed
REVVITY, INC.
2023-FY EPS reported
$5.55
revenue$2,750,571,000
- Q4 2023 revenue expected at least $690M, reported organic revenue decline of approx. 7% and non-COVID organic decline of 4% year-over-year.
- Full-year 2023 adjusted EPS expected to meet or exceed the guidance provided on October 30, 2023.
- Company will release Q4 and full-year 2023 results on February 1, 2024, with a conference call at 8:00 a.m. ET hosted by CEO Prahlad Singh.
- CEO Prahlad Singh presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024.